Form Bio
Austin, US · Founded 2022 · 4 known investors
Form Bio develops AI-driven software and bioinformatics tools for genetic medicine and genome engineering, enabling faster and safer design of gene therapies, protein engineering, and manufacturing optimization.
Founders & leadership
MC

Michelle Chen, PhD
DD

Doug Daniels
JN

Joe Nipko, PhD
AE

Amicia Elliott, PhD
DK

David Kiger
AA

Angela Anderson
CC

Christina Capehart
JS
John SpinaleDirector
BL
Benjamin LammDirector, Promoter
AB
Andrew BuseyExecutive Officer, Director, Promoter
KW
Kent WakefordExecutive Officer, Director, Promoter
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$16MraisedSep 2022 · 4 investors · BiotechnologyRule 506(b)
▶$16MraisedSep 2022 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John SpinaleDirector
- Benjamin LammDirector, Promoter
- Andrew BuseyExecutive Officer, Director, Promoter
- Kent WakefordExecutive Officer, Director, Promoter
- Offering amount
- $26.3M
- Amount sold
- $16M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
